Literature DB >> 27865283

Management of Locally Advanced Pancreatic Cancer.

Robert C G Martin1.   

Abstract

The diagnosis for locally advanced pancreatic cancer is based on high-quality cross-sectional imaging, which shows tumor invasion into the celiac/superior mesenteric arteries and/or superior mesenteric/portal venous system that is not reconstructable. The optimal management of these patients is evolving quickly with the advent of newer chemotherapeutics, radiation, and nonthermal ablation modalities. This article presents the current status of initial chemotherapy, surgical therapy, ablative therapy, and radiation therapy for patients with nonmetastatic locally advanced unresectable pancreatic cancer. Surgical resection offers the best chance of long-term disease control and the only chance for cure for patients with nonmetastatic exocrine pancreatic cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Algorithm; Locally advanced pancreatic cancer; Stage 3 pancreatic cancer; Treatment

Mesh:

Year:  2016        PMID: 27865283     DOI: 10.1016/j.suc.2016.07.010

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  6 in total

1.  Subharmonic and Endoscopic Contrast Imaging of Pancreatic Masses: A Pilot Study.

Authors:  Flemming Forsberg; Maria Stanczak; Andrej Lyshchik; David Loren; Patrick O'Kane; Ali Siddiqui; Thomas E Kowalski; Cynthia Miller; Traci Fox; Ji-Bin Liu; John R Eisenbrey
Journal:  J Ultrasound Med       Date:  2017-07-06       Impact factor: 2.153

2.  Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels.

Authors:  Concetta Panebianco; Nadia Trivieri; Annacandida Villani; Fulvia Terracciano; Tiziana Pia Latiano; Adele Potenza; Francesco Perri; Elena Binda; Valerio Pazienza
Journal:  Biomolecules       Date:  2021-04-26

3.  Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression.

Authors:  Takamichi Igarashi; Kenichiro Araki; Takehiko Yokobori; Bolag Altan; Takahiro Yamanaka; Norihiro Ishii; Mariko Tsukagoshi; Akira Watanabe; Norio Kubo; Tadashi Handa; Yasuo Hosouchi; Masahiko Nishiyama; Tetsunari Oyama; Ken Shirabe; Hiroyuki Kuwano
Journal:  Oncotarget       Date:  2017-02-14

4.  Case report: Irreversible electroporation for locally advanced pancreatic cancer.

Authors:  Sonia Orcutt; Bela Kis; Mokenge Malafa
Journal:  Int J Surg Case Rep       Date:  2017-09-01

5.  18F-labeled Dimer-Sansalvamide A Cyclodecapeptide: A Novel Diagnostic Probe to Discriminate Pancreatic Cancer from Inflammation in a Nude Mice Model.

Authors:  Xiaohui Wang; Jun Zhang; Zhijian Han; Liheng Ma; Yumin Li
Journal:  J Cancer       Date:  2022-03-21       Impact factor: 4.207

6.  Novel temperature-controlled RFA probe for treatment of blocked metal biliary stents in patients with pancreaticobiliary cancers: initial experience.

Authors:  Manu K Nayar; Kofi W Oppong; Noor L H Bekkali; John S Leeds
Journal:  Endosc Int Open       Date:  2018-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.